Skip to main content
. 2021 Feb 22;11(2):152. doi: 10.3390/jpm11020152

Figure 1.

Figure 1

Novel targeted therapeutic classes in follicular lymphoma (FL). Schematic diagram of novel agents grouped according to their mechanism of action. Abbreviations: BCR, B-cell receptor; PI3K, phosphatidylinositol-3-kinase; BTK, Bruton tyrosine kinase; SYK, spleen tyrosine kinase; mAb, monoclonal antibody; PD-1, programmed death-1; CAR, chimeric antigen receptor; NK, natural killer.